Investor rights law firm Halper Sadeh LLC is currently looking into the merger between Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) and Supernus Pharmaceuticals, Inc., with the closing of the Proposed Transaction set to result in Indivior shareholders possessing around 56.5% of the combined entity. Shareholders of Indivior are advised by Halper Sadeh to explore further details on their rights and choices. They can reach out to Daniel Sadeh or Zachary Halper at no cost via (212) 763-0060 or sadeh@halpersa.